ESSA Pharma Inc. — Director's Dealing 2022

Sep 22, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2022-09-13

Reporting Person: Kantoff Philip W. (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.39	2032-09-13	Common Stock (50000)		Direct

Footnotes

F1: Options vest over a three-year period in 36 monthly installments, with the first installment vesting on the one month anniversary of the award date, and subsequent installments vesting on each one month anniversary thereafter.